Premium
Systematic patient involvement for homebased outpatient administration of complex chemotherapy in acute leukemia and lymphoma
Author(s) -
Fridthjof Katrine S.,
Kampmann Peter,
Dünweber Anne,
Gørløv Jette S.,
Nexø Connie,
Friis Lone S.,
Nørskov Kristina H.,
Welinder Pernille C.,
Moser Claus,
Kjeldsen Lars,
Møller Tom
Publication year - 2018
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.15249
Subject(s) - medicine , carmustine , etoposide , chemotherapy , cytarabine , melphalan , regimen , lymphoma , oncology , surgery , intensive care medicine
Summary Based on experience with comprehensive patient involvement, we present data from implementation of portable, programmable infusion pumps ( PPP ) for home‐based chemotherapy administration in patients with acute leukaemia and in lymphoma patients receiving (carmustine, etoposide, cytarabine, melphalan) BEAM regimen. Data from 84 patients, receiving 177 cycles of PPP administered chemotherapy, showed convincing safety with minor equipment errors encountered and with high patient satisfaction. In‐hospital days could be reduced with 52% out of a total of 1197 treatment days. Homebased PPP has several advantages from a patient perspective and furthermore frees up in‐hospital beds for patients in need of them.